For example, sclerostin loop3-targeting aptamer (Apc001PE) accelerated bone formation in osteogenesis imperfecta (OI) mice without any cardiovascular risk, which is superior to OI antibodies, causing a potential heart attack, stroke, and cardiovascular death [185]. This evidence concerns the gene SOST and osteogenesis imperfecta.